Lumida
/CRNC
⌘K
Cerence Inc

Cerence Inc

CRNC
$8.51USD+4.55%+0.37 today

MARKET CAP

384.9M

P/E (TTM)

20.0x

FWD P/E

10.6x

DAY RANGE

$8 – $9

52W RANGE

$6
$14

AI Summary

Stalk
StalkMedium

CRNC remains in a Stage 2 advancing regime undergoing a corrective reset. The medium-term bias stays bullish on higher-highs/higher-lows intact above the rising 50 DMA, while short-term price is being rejected by the flattened 9/21 EMA zone. Execution is deferred (Stalk), with focus on pullbacks into 50 DMA support or upon reclaim and acceptance of the 9/21 EMAs.

  • Q3 revenue of $69.6M (+12% YoY) fuels growth narrative.
  • GAAP net income returned to $1.5M and adjusted EBITDA rose 50% to $13.5M.
  • Negative earnings yield and profitability scores signal weak returns.
Full analysis →

Buying

5

institutions

Selling

6

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY4.54 M51.43 M+373.02 K+95.4%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY1.17 M12.79 M+275.69 K+135.0%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY579.46 K6.56 M+36.24 K+91.4%0.00%
MM

Millennium Management LLC

Q2 2026

BUY292.95 K3.32 M+102.07 K+175.3%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUY262.57 K2.97 M+230.70 K+1378.1%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL120.30 K1.31 M+-7.01 K+72.0%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL97.35 K1.10 M+-96.34 K-9.8%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL1.22 K13.82 K+-386.00+36.3%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL0.000.00+-114.97 K-100.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL0.000.00+-40.27 K-100.0%0.00%
MG

Man Group Plc

Q2 2026

SELL0.000.00+-38.35 K-100.0%0.00%